AZITHROMYCIN, UNSPECIFIED FORM

Substance profile for UNII F94OW58Y8V, enriched with FDA NDC listings, DailyMed labels, legacy aliases, and open chemistry identifiers.

Substance Identity#

UNII
F94OW58Y8V
Preferred term
AZITHROMYCIN, UNSPECIFIED FORM
Ingredient type
UNSPECIFIED INGREDIENT

Chemical And Database Identifiers#

RxCUI
18631
PubChem
0
NCIt
C28844
INN ID
0

Open Chemistry Sources#

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIIDailyMed labelSPL versionUploaded
AZITHROMYCINACTIVE MOIETYF94OW58Y8VAZITHROMYCIN TABLETS USP, 250 mg and 500 mg 7146 7169 Rx only1
azithromycinACTIVE MOIETYF94OW58Y8VAZITHROMYCIN azithromycin tablets and azithromycin for oral suspension2
azithromycinACTIVE INGREDIENTF94OW58Y8VAZITHROMYCIN azithromycin tablets and azithromycin for oral suspension2
AZITHROMYCINACTIVE MOIETYF94OW58Y8V8f0b9785-1b5c-41f0-a6f2-80088aab18b11
AZITHROMYCINACTIVE MOIETYF94OW58Y8V9e5bb949-c9be-48cd-b0a2-6b7fd536e7771
AZITHROMYCINACTIVE MOIETYF94OW58Y8V32ae8f5a-ea78-4e64-a58a-856ed8cf4f781
azithromycinACTIVE MOIETYF94OW58Y8VThese highlights do not include all the information needed to use ZMAX safely and effectively. See full prescribing information for ZMAX. ZMAX (azithromycin) powder, for suspension for oral use Initial U.S. Approval: 19911
azithromycinACTIVE INGREDIENTF94OW58Y8VThese highlights do not include all the information needed to use ZMAX safely and effectively. See full prescribing information for ZMAX. ZMAX (azithromycin) powder, for suspension for oral use Initial U.S. Approval: 19911
AZITHROMYCINACTIVE MOIETYF94OW58Y8VAzithromycin Tablets 600 mg1
AZITHROMYCINACTIVE MOIETYF94OW58Y8Va7bf9202-9590-49c8-bde1-78517e60850f1
azithromycinACTIVE MOIETYF94OW58Y8VAZITHROMYCIN FOR ORAL SUSPENSION, USP 7148 7149 Rx only2
AZITHROMYCINACTIVE MOIETYF94OW58Y8V24ea9765-6d74-4681-8110-5a6fc0b04db51
AZITHROMYCINACTIVE MOIETYF94OW58Y8V6fadde9e-dab3-4d01-b3fb-795eef7eff2f1
AZITHROMYCINACTIVE MOIETYF94OW58Y8V966c8f58-fde1-4af0-964b-c0bddbb05b362
AZITHROMYCINACTIVE INGREDIENTF94OW58Y8V966c8f58-fde1-4af0-964b-c0bddbb05b362
AZITHROMYCINACTIVE MOIETYF94OW58Y8V4a13b574-ff5e-417e-bef4-279fcc3d52803
AZITHROMYCINACTIVE INGREDIENTF94OW58Y8V4a13b574-ff5e-417e-bef4-279fcc3d52803
AZITHROMYCINACTIVE MOIETYF94OW58Y8VAZITHROMYCIN TABLET, FILM COATED [LAKE ERIE MEDICAL & SURGICAL SUPPLY DBA QUALITY CARE PRODUCTS LLC]3421
AZITHROMYCINACTIVE INGREDIENTF94OW58Y8VAZITHROMYCIN TABLET [LAKE ERIE MEDICAL DBA QUALITY CARE PRODUCTS LLC]3042
AZITHROMYCINACTIVE MOIETYF94OW58Y8VAZITHROMYCIN TABLET [LAKE ERIE MEDICAL DBA QUALITY CARE PRODUCTS LLC]3042
azithromycinACTIVE MOIETYF94OW58Y8VZITHROMAX (AZITHROMYCIN) TABLET, FILM COATED [PD-RX PHARMACEUTICALS, INC.]9
AZITHROMYCINACTIVE INGREDIENTF94OW58Y8VAZITHROMYCIN TABLET [REMEDYREPACK INC. ]6
AZITHROMYCINACTIVE INGREDIENTF94OW58Y8VAZITHROMYCIN (AZITHROMYCIN ANHYDROUS) TABLET [REMEDYREPACK INC. ]4
AZITHROMYCIN, UNSPECIFIED FORMACTIVE INGREDIENTF94OW58Y8VAZITHROMYCIN TABLET, FILM COATED [REMEDYREPACK INC. ]3
AZITHROMYCIN, UNSPECIFIED FORMACTIVE INGREDIENTF94OW58Y8VAZITHROMYCIN TABLET, FILM COATED [REMEDYREPACK INC. ]2
AZITHROMYCINACTIVE MOIETYF94OW58Y8VAZITHROMYCIN (AZITHROMYCIN FOR INJECTION INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION) INJECTION [APOTEX CORP.]1
AZITHROMYCINACTIVE MOIETYF94OW58Y8VAZITHROMYCIN INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [CARDINAL HEALTH]1
AZITHROMYCINACTIVE MOIETYF94OW58Y8VAZITHROMYCIN TABLET [REMEDYREPACK INC. ]1
AZITHROMYCINACTIVE INGREDIENTF94OW58Y8VAZITHROMYCIN TABLET [REMEDYREPACK INC. ]1
AZITHROMYCINACTIVE INGREDIENTF94OW58Y8VAZITHROMYCIN TABLET, FILM COATED [KAISER FOUNDATION HOSPITALS]1
AZITHROMYCINACTIVE MOIETYF94OW58Y8VAZITHROMYCIN TABLET, FILM COATED [KAISER FOUNDATION HOSPITALS]1
AZITHROMYCIN, UNSPECIFIED FORMACTIVE INGREDIENTF94OW58Y8VZITHROMAX (AZITHROMYCIN) TABLET, FILM COATED [REMEDYREPACK INC. ]1
AZITHROMYCIN, UNSPECIFIED FORMACTIVE INGREDIENTF94OW58Y8VZITHROMAX (AZITHROMYCIN) TABLET, FILM COATED [REMEDYREPACK INC. ]1